Document is current
Any future updates will be listed below
-
Authors
Kvien, Tore K. https://orcid.org/0000-0002-8441-3093
Betteridge, Neil https://orcid.org/0000-0001-8844-1158
Brückmann, Ines
Bodenmüller, Wolfram
Bryn, Galyna
Danese, Silvio https://orcid.org/0000-0001-7341-1351
Gonçalves, João
Maravic, Zorana https://orcid.org/0000-0001-6263-0313
Thorne, Carter https://orcid.org/0000-0002-1721-190X
Wingate, Laura https://orcid.org/0000-0002-0298-6948
Cornes, Paul https://orcid.org/0000-0002-7835-7873
-
Funding
Funding for this research was provided by:
Sandoz Group AG
Diakonhjemmet Hospital
- License Information
-
More Information
Article History
Accepted: 5 May 2025
First Online: 5 June 2025
Declarations
:
: T.K.K. reports fees for speaking and/or consulting from AbbVie, Amgen, Celltrion, Egis, Ewopharma, Gilead, Hikma, Janssen, Mylan, Novartis, Oktal, Pfizer, Sandoz, and UCB; and research funding from AbbVie, BMS, Galapagos, MSD, Novartis, Pfizer, and UCB. N.B. declares consultancy fees received from EULAR, Galapagos, Grunenthal, and Sanofi. I.B., W.B., and G.B. are employees of Sandoz. S.D. declares consultancy fees from AbbVie, Alimentiv, Allergan, Amgen, AstraZeneca, Athos Therapeutics, Biogen, Boehringer Ingelheim, Celgene, Celltrion, Eli Lilly, Enthera, Ferring Pharmaceuticals, Gilead, Hospira, Inotrem, Janssen, Johnson & Johnson, MSD, Mundipharma, Mylan, Pfizer, Roche, Sandoz, Sublimity Therapeutics, Takeda, TiGenix, UCB, and Vifor; and speaker fees from AbbVie, Amgen, Dr Falk Pharma, Ferring Pharmaceuticals, Gilead, Janssen, Mylan, Pfizer, and Takeda. J.G. declares speaker fees from AstraZeneca, Celltrion, Chiesi, Sandoz, and Sanofi. Z.M. has no conflicts of interest to declare. C.T. declares consultancy fees received from Biogen, Nordic, Pfizer, and Sandoz; advisory board fees from AbbVie, Nordic, Pfizer, Roche, and Sandoz; and research grants from Jamp and Pfizer. L.W. declares advisory fees received from Act4Biosimilars and PAN Therapeutics. P.C. declares speaker fees from Celltrion, Viatris (formerly Mylan), Pfizer, Novartis, and Sandoz.
: This study was funded by Sandoz Group AG. The funder had a role in the study design, data collection, data analysis, and manuscript preparation. The open access fee was also sponsored by Sandoz Group AG.
: Not applicable.
: Not applicable.
: Data available on request.
: Not applicable.
: I.B., W.B., and G.B. contributed to the study design, literature search, and data analysis. N.B., Z.M., C.T., and L.W. contributed to the study design, data analysis, and manuscript development. T.K.K., J.G., and P.C. contributed to the study design and manuscript development. All authors were involved in the preparation and review of the manuscript. All authors read and approved the final manuscript.
